Journal article · 2009

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making

Jan Volavka, Leslie Citrome

Expert Opinion on Pharmacotherapy, 10(12), 1917–1928 · Published 28 June 2009 · DOI 10.1517/14656560903061309

View at the publisherCite this paper

In brief

“Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making” is a 2009 journal article by Jan Volavka and Leslie Citrome, published in Expert Opinion on Pharmacotherapy. OpenAlex counts 81 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
81
Most cited in
2016 (8)
Field-weighted impact
4.20
References
89
Authors
2

Abstract

BACKGROUND: Antipsychotic medications are conventionally divided into two groups: First-generation and second-generation antipsychotics (FGAs and SGAs). There is a disagreement about the role of these two groups in the treatment of schizophrenia. OBJECTIVE: To analyze the reasons for the disagreement and to propose a resolution that would improve the treatment of schizophrenia. METHOD: An overview… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Volavka, J., & Citrome, L. (2009). Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert Opinion on Pharmacotherapy, 10(12), 1917–1928. https://doi.org/10.1517/14656560903061309

MLA 9

Volavka, Jan, and Leslie Citrome. “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.” Expert Opinion on Pharmacotherapy, vol. 10, no. 12, 2009, pp. 1917–1928. https://doi.org/10.1517/14656560903061309.

Chicago

Volavka, Jan and Leslie Citrome. 2009. “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.” Expert Opinion on Pharmacotherapy 10 (12): 1917–1928. https://doi.org/10.1517/14656560903061309.

Harvard

Volavka, J. and Citrome, L. (2009) ‘Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making’, Expert Opinion on Pharmacotherapy, 10(12), pp. 1917–1928. doi:10.1517/14656560903061309.

IEEE

J. Volavka and L. Citrome, “Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making,” Expert Opinion on Pharmacotherapy, vol. 10, no. 12, pp. 1917–1928, 2009, doi: 10.1517/14656560903061309.

BibTeX

@article{volavka2009oral,
  title     = {{Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making}},
  author    = {Volavka, Jan and Citrome, Leslie},
  journal   = {Expert Opinion on Pharmacotherapy},
  year      = {2009},
  volume    = {10},
  number    = {12},
  pages     = {1917--1928},
  doi       = {10.1517/14656560903061309},
  url       = {https://doi.org/10.1517/14656560903061309}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201688
201733
201855
201911
202011
202122
202244
202344
202466
202511

Its field-weighted citation impact is 4.20: it has been cited 4.20 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • schizophrenia
  • antipsychotic drugs
  • typical antipsychotics
  • atypical antipsychotics
  • antipsychotic efficacy
  • antipsychotic tolerability
  • extrapyramidal symptoms
  • tardive dyskinesia

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Volavka, J., & Citrome, L. (2009). Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert Opinion on Pharmacotherapy, 10(12), 1917–1928. https://doi.org/10.1517/14656560903061309

How many times has this paper been cited?

81 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Jan Volavka, Leslie Citrome.

What is the DOI of this paper?

10.1517/14656560903061309, permanently at https://doi.org/10.1517/14656560903061309. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.